| | | | | |
| $32,1720 | +1,30% | $280,50M | $7,40K | |
DBL DOUBLELINE OPPORTUNISTIC CREDIT FUND | $14,1080 | +0,13% | $280,16M | $10,16K | |
TSI TCW Strategic Income Fund, Inc. | $4,3750 | +0,34% | $279,70M | $46,23K | |
PAII Pyrophyte Acquisition Corp. II | $10,2650 | +0,05% | $279,21M | $21,00 | |
| $13,8900 | -5,06% | $279,07M | $167,11K | |
YDES YD Bio Limited Ordinary Shares | $4,5080 | -3,88% | $279,07M | $4,14K | |
XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares | $9,9940 | +0,04% | $278,71M | $16,00 | |
RWAY Runway Growth Finance Corp. Common Stock | $6,6050 | -0,53% | $278,70M | $117,60K | |
JILL J.Jill, Inc. Common Stock | $20,6560 | +2,21% | $278,69M | $14,52K | |
LCTX Lineage Cell Therapeutics, Inc. | $1,0950 | +1,39% | $278,19M | $329,93K | |
AXIN Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares | $10,3250 | +0,15% | $278,12M | $12,17K | |
ACV Virtus Diversified Income & Convertible Fund | $26,6600 | +0,04% | $278,09M | $1,91K | |
ALXO ALX Oncology Holdings Inc. Common Stock | $1,9850 | -2,70% | $277,93M | $96,32K | |
| $1,4050 | -1,75% | $277,83M | $72,44K | |
YSG Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares | $3,0350 | +1,17% | $277,66M | $19,06K | |
